Condition 1: Chronic kidney disease, stage 5. Condition 2: Adjustment and management of vascular access. Chronic kidney disease, stage 5 Encounter for adjustment and management of vascular access device
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with chronic renal failure who are candidates for AVF implantation. Give informed consent to participate in the study
Exclusion criteria
Exclusion criteria: Patients with Central Vein Stenosis Body Mass Index (BMI)>30 BMI<20 Impossibility of implementing the exercise protocol (intervention) due to physical or mental disability or lack of social support
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The thickness of the vein wall. Timepoint: The thickness of the vein wall at the beginning of the study (before the start of the intervention) and 1 and 21 days after AVF implantation. Method of measurement: Doppler Sonography.;Vein diameter. Timepoint: The Vein diameter at the beginning of the study (before the start of the intervention) and 1 and 21 days after AVF implantation. Method of measurement: Doppler Sonography.;The distance between the vein and the skin. Timepoint: The distance between the vein and the skin at the beginning of the study (before the start of the intervention) and 1 and 21 days after AVF implantation. Method of measurement: Doppler Sonography.;Blood Flow Rate(BFR). Timepoint: BFR On the 1st and 21st days after arterio-venous fistula implantation. Method of measurement: Doppler Sonography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Esfahan University of Medical Sciences